Molecular Vision 2008; 14:2042-2055 <>
Received 20 October 2008 | Accepted 7 November 2008 | Published 12 November 2008

The EPHA2 gene is associated with cataracts linked to chromosome 1p

Alan Shiels,1,2 Thomas M. Bennett,1 Harry L.S. Knopf,1 Giovanni Maraini,3 Anren Li,4 Xiaodong Jiao,4 J. Fielding Hejtmancik4

1Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, MO; 2Department of Genetics, Washington University School of Medicine, St. Louis, MO; 3Department of Ophthalmology, University of Parma, Parma, Italy; 4Ophthalmic Genetics and Visual Function Branch, National Eye Institute, National Institutes of Health, Bethesda, MD

Correspondence to: Dr. Alan Shiels, Department of Ophthalmology and Visual Sciences, Campus Box 8096, Washington University School of Medicine, 660 South Euclid Avenue, St. Louis, MO, 63110; Phone: (314) 362-1637; FAX: (314) 362-1646; email:


Purpose: Cataracts are a clinically and genetically heterogeneous disorder affecting the ocular lens, and the leading cause of treatable vision loss and blindness worldwide. Here we identify a novel gene linked with a rare autosomal dominant form of childhood cataracts segregating in a four generation pedigree, and further show that this gene is likely associated with much more common forms of age-related cataracts in a case-control cohort.

Methods: Genomic DNA was prepared from blood leukocytes, and genotyping was performed by means of single nucleotide polymorphism (SNP) markers, and short tandem repeat (STR) markers. Linkage analyses were performed with the GeneHunter and MLINK programs, and association analyses were performed with the Haploview and Exemplar programs. Mutation detection was achieved by PCR amplification of exons and di-deoxy cycle-sequencing.

Results: Genome-wide linkage analysis with SNP markers, identified a likely disease-haplotype interval on chromosome 1p (rs707455-[~10 Mb]-rs477558). Linkage to chromosome 1p was confirmed using STR markers D1S2672 (LOD score [Z]=3.56, recombination distance [θ]=0), and D1S2697 (Z=2.92, θ=0). Mutation profiling of positional-candidate genes detected a heterozygous transversion (c.2842G>T) in exon 17 of the gene coding for Eph-receptor type-A2 (EPHA2) that cosegregated with the disease. This missense change was predicted to result in the non-conservative substitution of a tryptophan residue for a phylogenetically conserved glycine residue at codon 948 (p.G948W), within a conserved cytoplasmic domain of the receptor. Candidate gene association analysis further identified SNPs in the EPHA2 region of chromosome 1p that were suggestively associated with age-related cataracts (p=0.007 for cortical cataracts, and p=0.01 for cortical and/or nuclear cataracts).

Conclusions: These data provide the first evidence that EPHA2, which functions in the Eph-ephrin bidirectional signaling pathway of mammalian cells, plays a vital role in maintaining lens transparency.


Light scattering opacities of the crystalline lens, or cataracts, are a common ocular symptom of aging (>50 years), and despite advances in their surgical treatment age-related cataracts remain a leading cause of visual impairment, accounting for ~40% of world blindness [1]. Rarely, cataracts may present at birth (congenital), during infancy or during childhood with an estimated prevalence of 1–13 cases/10,000 live births [2], and are clinically important as a cause of impaired form vision development accounting for 5%–20% of childhood blindness [3]. As much as 40% of early-onset cataracts may have a genetic basis [2], either as a recognized feature of over 50 genetic syndromes, involving other ocular defects (e.g., microphthalmia) and systemic abnormalities (e.g., galactokinase deficiency), or more often as an isolated lens phenotype with autosomal dominant inheritance (Online Mendelian Inheritance in Man; OMIM). To date, genetic linkage studies of over 70 extended families worldwide have mapped at least 25 independent loci for clinically diverse forms of nonsyndromic cataracts on 18 human chromosomes [4]. The majority of underlying mutations have been identified in 10 crystallin genes (CRYAA, CRYAB, CRYBB1, CRYBB2, CRYBB3, CRYBA3/A1, CRYBA4, CRYGC, GRYGD, and CRYGS) [5-13] and 2 connexin genes (GJA3, GJA8) [14,15], which encode the major “refractive” proteins and gap-junction-channel proteins of the lens, respectively. The remaining mutations have been identified in at least 10 other functionally diverse genes including those coding for transcription factors (HSF4, MAF, PITX3) [16-18], an aquaporin water channel (MIP) [19], cell-junction-like proteins (LIM2, TMEM114) [20,21], intermediate-filament-like proteins (BFSP2, BFSP1) [22,23], a chromatin modifying protein (CHMP4B) [24], and a solute carrier protein (SLC16A12) [25].

In addition to conventional linkage studies of inherited cataracts in extended families, sibling and twin studies indicate that genetic risk factors may account for 14%–48% of the heritability for age-related “nuclear” cataracts [26-28], and 24%–75% of the heritability for age-related “cortical” cataracts [29-31]. In contrast to inherited cataracts; however, comparatively little is known about the underlying genetic determinants predisposing to age-related cataracts [32]. Genes linked with inherited forms of cataracts represent likely candidate genes for age-related cataracts; however, only the “Osaka” variation (p.A198V) in the gene for autosomal recessive galactokinase-deficiency and congenital cataracts (GALK1) has so far been associated unambiguously with age-related cataracts, and this association appears to be limited to East Asian populations [33,34]. Here we report for the first time that variations in the gene for Eph-receptor tyrosine kinase-type A2 (EPHA2) on 1p36 are associated with inherited and age-related forms of cataracts in Caucasians.


Family participants

A white American family of Western European origin (family Mu) was ascertained through ophthalmic records in the Department of Ophthalmology and Visual Sciences at Washington University School of Medicine, St. Louis, MO. Blood samples were obtained from 18 family members including 12 affected individuals, one unaffected individual, and five spouses. Leukocyte genomic DNA was purified using the Gentra Puregene Blood kit (Qiagen, Valencia, CA), and quantified by absorbance at 260nm (GeneQuant pro; GE Healthcare, Waukesha, WI). Ethical approval for this study was obtained from the Washington University Human Research Protection Office, and written informed consent was provided by all participants before enrollment in accordance with the tenets of the Declaration of Helsinki, and Health Insurance Portability and Accountability Act (HIPAA) regulations.

Case-control participants

A case-control cohort of unrelated individuals aged >50 years form Northern Italy was ascertained from the Clinical Trial of Nutritional Supplements and Age-Related Cataract Study [35]. Genomic DNA was purified from blood samples as described previously [34], and lens status was evaluated by grading slit-lamp and retro-illumination lens photographs according to a modification of the Age-Related Eye Disease Study (AREDS) cataract grading system [36]. Briefly, a clear lens was defined by the following grades at the last available grading: nuclear opalescence <3.0; cortical opacity <5% within the five mm diameter (dia) circle at the center of the pupil, and <15% outside this central five mm dia circle; posterior sub-capsular opacity <1.0 % within the five mm dia central circle. A lens was defined as cataractous when at least one type of opacity was present with one or more of the following grades: nuclear opalescence ≥4.5; cortical opacity >25% inside five mm dia central circle and/or >25% outside five mm dia circle; posterior sub-capsular opacity >12.5% inside five mm dia circle. Ethical approval for this study was obtained from the University of Parma and the National Eye Institute, and written informed consent was provided in accordance with the tenets of the Declaration of Helsinki.

SNP genotyping and linkage analysis

For genome-wide linkage analysis, genotyping was performed by means of the HumanLinkage-12 Genotyping Beadchip and the Infinium-II whole-genome amplification and single-base extension assay (Illumina, San Diego CA) in the Microarray Core Facility at Washington University Genome Center. Parametric multipoint linkage analysis performed with GeneHunter version 2.1r5 from the easyLINKAGE Plus version 5.08 package [37]. SNP marker allele frequencies used for linkage analysis were those calculated for Caucasians by the HapMap project. A gene frequency of 0.001 and a penetrance of 100% were assumed for the disease locus. Computation was performed with GeneHunter in sets of 100 markers.

STR genotyping and linkage analysis

STR markers from the National Center for Biotechnology Information (NCBI) combined Généthon, Marshfield, and deCODE genetic linkage maps were genotyped by means of a 4200 DNA analyzer running Gene ImagIR software (Li-Cor, Lincoln, NE) as described previously [38]. Pedigree and haplotype data were managed using Cyrillic (v.2.1) software (FamilyGenetix Ltd., Reading, UK), and two-point LOD scores (Z) calculated using the MLINK sub-program from the LINKAGE (5.1) package of programs [39]. Marker allele frequencies were assumed to be equal, and a gene frequency of 0.0001 with a penetrance of 100% were assumed for the disease locus.

Mutation analysis

The genomic sequence for EPHA2 was obtained from the Ensembl human genome browser, and gene-specific M13-tailed PCR primers (Table 1) were selected from the NCBI re-sequencing amplicon (RSA) probe database. Genomic DNA (2.5 ng/ul, 20 ul reactions), was amplified (35–40 cycles) in a GeneAmp 9700 thermal cycler using AmpliTaq polymerase (Applied Biosystems, Foster City, CA) and gene-specific primers (10 pmol). Resulting PCR amplicons (~250–650 bp) were either enzyme-purified with ExoSAP-IT (USB Corporation, Cleveland, OH) or gel-purified with the QIAquick gel-extraction kit (Qiagen). Purified amplicons were direct cycle-sequenced in both directions with BigDye Terminator Ready Reaction Mix (version 3.1) containing M13 forward or reverse sequencing primers then ethanol precipitated and detected by capillary electrophoresis on a 3130xl Genetic Analyzer running Sequence Analysis (version 5.2) software (Applied Biosystems), and Chromas (version 2.23) software (Technelysium, Tewantin, Queensland, Australia). For allele-specific PCR analysis, exon-17 was amplified with three primers (Ex17R1, Ex17SF, and T-alleleF; Table 1), and resulting amplicons were visualized at 302 nm following electrophoresis in 3% agarose-gels stained with GelRed (Biotium, Hayward, CA).

SNP association analysis

For association studies, tagging SNPs covering the EPHA2 region were selected from the HapMap database using the Haploview program [40]. SNPs were genotyped by a combination of TaqMan melt-curve assays “on-demand” (Applied Biosystems), SNaPshot single-base extension assays (Applied Biosystems), and direct BigDye Terminator cycle-sequencing (Applied Biosystems). TaqMan assays were run on a 7900 HT real-time PCR system (Applied Biosystems). SNaPshot assays and di-deoxy cycle-sequencing were performed on a 3130 DNA analyzer (Applied Biosystems), and sequence analysis was performed with the Mutation Surveyor program (Soft Genetics, State College, PA).

Statistical analyses

Tagging SNPs and haplotype blocks were identified using the Haploview program [40], and association statistics including χ2, trend p values, and odds ratios were calculated using the Exemplar program version 4.04 (Sapio Sciences, York, PA). Hardy–Weinberg equilibrium was assessed using a χ2 test implemented in the Exemplar program.


Linkage studies

We investigated a four generation white family from the United States (family Mu) segregating “posterior polar” cataracts in the absence of systemic abnormalities (Figure 1A). Autosomal dominant inheritance was supported by father-to-son transmission in the absence of gender bias or skipping of generations. Ophthalmic records indicated that the cataracts usually presented in both eyes as disc-shaped posterior sub-capsular opacities with evidence of posterior lenticonus (Figure 1B). In three affected individuals, opacification progressed to affect the central (nucleus) and anterior polar regions of the lens (IV:5, IV:6, IV:7; Figure 1A). In addition to cataracts, one affected individual had monocular amblyopia (III:8), and two others developed strabismus requiring corrective surgery (IV:1, IV:5). The age-at-diagnosis varied from birth to15 years, and the age-at-surgery ranged from 0 to 44 years. Post-surgical corrected visual acuity varied from 20/20 to 20/70 in the better eye.

For genome-wide linkage analysis, the 12 affected individuals in family Mu were genotyped by means of the HumanLinkage-12 Panel (Illumina), which comprises 6090 SNP markers uniformly spaced at an average genetic distance of 0.58 cM. Parametric multipoint analysis performed with GeneHunter (v2.1r5) detected significant evidence of linkage (Figure 2) on chromosome 1p (pLOD 3.3), and weak evidence of linkage on chromosome 17p (pLOD 1.8). Haplotype reconstruction further identified a common disease interval on 1p36 (rs707455-[~10Mb]-rs477558) that cosegregated with the disease in all 12 affected individuals (Table 2).

To validate the authentic SNP interval from the genome-wide linkage scan, all 18 family members were genotyped with STR markers. We first excluded false-positive linkage to the SNP interval on 17p using markers D17S1852 (Z=-3.75, θ=0) and D17S921 (Z=-∞, θ=0, data not shown). Subsequently, we obtained confirmatory evidence of linkage on 1p (Table 3) for markers D1S2672 (Z=3.56, θ=0), D1S2697 (Z=2.92, θ=0), and D1S436 (Z=2.84, θ=0). Haplotype analysis detected four recombinant individuals within the Mu pedigree (Figure 1A). An affected female (III:8), her affected son (IV:5), and two affected daughters (IV:6, IV:7) were obligate recombinants distal to the centromere at D1S214. In addition, one of the affected daughters (IV:6) was recombinant proximal to the centromere at D1S2644. However, no further recombinant individuals were detected at five other intervening STR markers, consistent with the cataract locus residing in the physical interval, D1S214-(~12 Mb)-D1S2644 (Figure 1C), which was coincident with the SNP interval on 1p.

Mutation analysis

The SNP and STR intervals contained 211 and 219 positional-candidate genes, respectively, none of which were obvious functional candidates for cataracts in family Mu (NCBI Map Viewer). We prioritized genes for mutation analysis of exons and intron boundaries (splice-sites) primarily based on evidence of expression or function in the eye, from the NCBI UniGene expressed sequence tag (EST) database, and the NEIBank bioinformatics resource for vision research [41]. Re-sequencing analysis of individuals II:1, III:8, and III:9 from the Mu pedigree (Figure 1A) excluded the presence of coding or splice-site mutations in several genes including ENO1 (GeneID: 2023), which according to NEIBank is abundantly expressed in the human lens. However, re-sequencing of a 17-exon gene symbolized EPHA2 (GeneID: 1969), which is also expressed in human lens (NEIBank), identified a heterozygous c.2842G>T transversion in exon-17 that was not present in wild type (Figure 3B). This single nucleotide change did not result in the gain or loss of a convenient restriction site, therefore we designed allele-specific (G/T) PCR analysis to confirm that the mutant “T” allele cosegregated with affected but not unaffected members of family Mu (Figure 3C). Furthermore, when we tested the c.2842G>T transversion as a bi-allelic marker, with a notional allelic frequency of 1%, in a two-point LOD score analysis of the cataract locus (Table 3) we obtained further compelling evidence of linkage (Z=3.61, θ=0). In addition, we confirmed that the c.2842G>T transversion was not listed in the NCBI SNP database (dbSNP), and excluded it as a SNP in a panel of 192 normal unrelated individuals (i.e., 384 chromosomes) using the allele-specific PCR analysis described in Figure 3C (data not shown). While it is possible that an undetected mutation lay elsewhere within the disease-haplotype interval, our genotype data strongly suggested that the c.2842G>T transversion in exon 17 of EPHA2 represented a causative mutation rather than a benign SNP in linkage disequilibrium with the cataract phenotype.

The c.2842G>T transversion identified above occurred at the first base of codon 948 (GGG >TGG), and was predicted to result in the missense substitution of glycine to tryptophan (p.G948W) at the level of translation (Figure 4), placing it in the cytoplasmic sterile-α-motif (SAM) domain of EPHA2 [42,43]. Cross-species alignment of the amino acid sequences for EPHA2 present in the Entrez protein database, performed by means of ClustalW multiple sequence alignment, revealed that p.G948 is evolutionarily conserved within the bony vertebrates (Figure 4B). Moreover, the predicted p.G948W substitution represented a nonconservative amino acid change, with the small neutral, polar side-group (-H) of glycine replaced by the much larger neutral, hydrophobic side-group (-CH2-C8 H4NH) of tryptophan. Position specific score matrix analysis (PSSM Viewer) revealed a marked decline in value from +6 to −6 (Table 4) confirming that the predicted p.G948W substitution occurred less frequently than expected in proteins with the conserved SAM domain (Conserved Domain Database [CDD] pfam00536) further raising the likelihood of functional consequences.

Association studies

EPHA2 resides within a large interval (D1S468-[~25.5 Mb]-D1S1622) on chromosome 1p (Figure 1C) that was previously linked with age-related cortical cataracts in families and sib-pairs from the Beaver Dam Eye Study [44]. To investigate the possibility that EPHA2 was associated with age-related cataracts, we performed candidate-gene SNP allele association studies in a case-control cohort from Northern Italy [34,35]. This clinically well defined cohort was of similar European ancestry to that of family Mu, and comprised 126 unrelated individuals with nuclear cataracts, 119 with cortical cataracts, and 104 unrelated controls with clear lenses (Table 5). Of the cases, 28 had both nuclear and cortical cataracts, three had nuclear and posterior sub-capsular cataracts, 10 had cortical and posterior sub-capsular cataracts, and four had nuclear, cortical, and posterior sub-capsular cataracts.

In an initial screen, tagging SNPs covering the EPHA2 region were genotyped using 100 samples each from individuals with any nuclear, any cortical and no age-related cataracts. Markers yielding p values <0.05 were further analyzed using the entire complement of samples (Appendix 1, Figure 5). All markers were in Hardy–Weinberg equilibrium (HWE, p>0.05) for all sample groups tested. The highest levels of association occurred with rs7543472 (allelic p<0.038 for cortical cataracts, and allelic p<0.021 for any age related cataracts) and rs11260867 (allelic p<0.020 for cortical cataracts), which lie just distal (3′) to EPHA2 (Figure 5). However, there was no significant association with nuclear cataracts, although results with rs7543472 were suggestive (allelic p<0.071, Appendix 1). These findings were true whether the analysis was for pure cortical cataracts, any cortical cataracts, pure nuclear cataracts, or any nuclear cataracts. Since association was seen between SNPs in the EPHA2 region and cortical cataracts and suggestive results were obtained with nuclear cataracts, the analysis was extended to include any age-related cataracts with subsequent increased association in SNPs from the peak region to p<0.021 with the T-allele of rs7543472, although the G-allele of rs11260867 actually lost significance slightly (p=0.076). Results for SNPs outside this region changed only minimally. Because the SNPs showing the greatest association lay over or just beyond exon 17, this region was sequenced in all samples. The only variation occurring with a frequency greater than 0.05 was rs3754334, a synonymous p.I958I (C3011T) variant. This variant had minor allele frequencies of ~34% in cataract cases and 28% in controls, and was thus analyzed further, although the association was not as strong as with the two distal (3′) SNPs (rs7543472 or rs11260867) and no significant allelic p values were obtained. Allelic odds ratios ranged from 1.5 to 1.7, for rs7543472, and 1.2–1.9 for rs11260867, but were not significant for rs3754334. The p values obtained were not corrected for multiple testing as these SNPs were tested, a priori, for association with age-related cataracts on the basis of their close proximity to a gene linked with inherited cataracts that also maps within a known linkage region for age-related cataracts, rather than as part of a genome-wide scan.

Trend p values were very similar to allelic p values for all SNPs, but the specific genotypes show greater levels of association for all SNPs showing significant association (Appendix 1). The most significant was p<0.007 for cortical cataracts with rs11260867 (GG genotype), p<0.012 for cortical cataracts and p<0.01 for any cataracts with rs7543472 (TT genotype), and p<0.019 for cortical cataracts and p<0.028 for any cataracts with rs3754334 (TT genotype). In addition, association of nuclear cataracts with the TT genotype of rs7543472 is marginally significant at p<0.042 and suggestive with the TT genotype of rs3754334 at p<0.06. Genotypic odds ratios show the greatest risk increase in individuals homozygous for the risk alleles, ranging from 1.9 to 2.1 for rs7543472, 1.5–2.3 for rs11260867, and 2.7–3.3 for rs3754334, depending on the type of age-related cataracts being considered (Appendix 1).

The association of a potential risk haplotype for these three SNPs was examined; however, the association level was found to be essentially that of the least associated SNP. This result was consistent with the observation that all but 4 affected individuals with the homozygous TT genotype for rs3754334 also had a homozygous TT genotype for rs7543472, and all but one had a homozygous GG genotype for rs11260867. Similarly, of affected individuals with a homozygous TT genotype for rs7543472 only a single individual did not have a homozygous GG genotype for rs11260867. However, because the genotype frequency of TT for rs3754334 was only ~15% it did not show strong linkage disequilibrium with rs11260867 (D´=0.018) or rs7543472 (D´=0.022). In contrast, rs11260867 and rs7543472, for which the risk genotypes have frequencies of ~80% and ~73% respectively, showed strong linkage disequilibrium (D´=0.896).


In this study, we have mapped an interval on human chromosome 1p36 for autosomal dominant posterior polar cataracts, and identified an underlying missense mutation (p.G948W) in the gene coding for EPHA2, which has not previously been associated with eye disease. Our disease interval maps in close proximity to autosomal dominant loci for the Volkman congenital cataract (CCV) in a Danish family [45], posterior polar cataract (CCTP1) in a British family [46], and total congenital cataract in a Tasmanian family [47], raising the possibility of allelism (Figure 1C). In addition, EPHA2 resides within a large interval (D1S468-[~25.5 Mb]-D1S1622) on chromosome 1p (Figure 1C) that was previously linked with age-related cortical cataracts in families and sib-pairs from Beaver Dam, Wisconsin [44]. Here, we further demonstrate that variations in the EPHA2 region are associated with age-related cortical cataracts (p=0.007), and age-related cataracts overall (p=0.01) in an Italian population.

EPHA2 encodes a 976 amino acid, type-1 transmembrane protein (~108 kDa) with extracellular NH2-terminal and cytoplasmic COOH-terminal halves (Figure 4B) [42]. The extracellular region comprises a conserved Eph-ligand binding domain followed by a cysteine-rich EGF-like domain, and two fibronectin type-III repeats, whereas, the cytoplasmic region contains a conserved tyrosine kinase domain, and a sterile-α-motif (SAM) domain [42]. The proposed p.G948W missense substitution, cosegregating with cataracts in family Mu, was predicted to reside in the cytoplasmic SAM domain of EPHA2. The evolutionarily conserved ~70 amino acid SAM domain has a compact helical structure that is believed to facilitate protein–protein interactions [43], raising the possibility that the predicted p.G948W substitution may interfere with Eph-receptor oligomerization and clustering into higher-order complexes essential for physiologic signaling [42].

In contrast to the heterozygous genotype and dominant phenotype linked with the p.G948W mutation in EPHA2, the SNPs in the EPHA2 region most associated with age-related cataracts displayed the highest odds ratios when homozygous for the risk allele, consistent with recessive effects. Furthermore, the p.G948W mutation was linked with posterior polar cataracts, which most resemble age-related posterior sub-capsular cataracts, whereas, EPHA2 SNPs were associated with much more prevalent forms of age-related cataracts, in decreasing order of significance; cortical opacities > any opacities > nuclear opacities. While it is problematic to compare inherited and age-related forms of cataracts, it is noteworthy that some of the affected members of family Mu also developed nuclear and anterior polar opacities. These observations raise the possibility that EPHA2 variants may contribute to a common pathogenic mechanism resulting in different cataract phenotypes. The existence of any such mechanism remains to be determined; however, it is interesting that the two SNPs in the EPHA2 region most associated with age-related cataracts (rs7543472 and rs11260867) lie outside the coding region near the 3′-end of the gene, which has been shown to harbor highly conserved translational control sequences that are believed to facilitate an RNA-based post-transcriptional mechanism for localized regulation of gene expression within cells [48,49].

EPHA2 is a member of the largest sub-family of receptor tyrosine kinases, which are divided into 2 classes; the A-subclass comprising 10 receptor genes (EPHA1–10) and the B-sub-class with 6 receptor genes (EPHB1–6) [50,51]. Ephreceptors interact with their cognate membrane-anchored ligands, referred to as ephrins (EFNA1–6, EFNB1–3), at cell-cell contact sites to activate bidirectional signaling pathways effecting diverse physiologic processes including; cell adhesion, repulsion, morphology, and migration [50,51]. Intriguingly, EPHA2 has been implicated in tumor angiogenesis and neurite outgrowth; however, little is known about its role in the development and homeostasis of the avascular, noninnervated lens. Recently, however, it has been reported that mice lacking ephrin-A5, a ligand of Epha2, develop cataracts as a result of impaired lens fiber cell adhesion [52]. Further characterization of Eph-ephrin signaling pathways in the lens should provide insight into the pathogenetic mechanisms linking EPHA2 dysfunction with cataractogenesis.

In conclusion, our data have associated EPHA2 with both inherited and age-related cataracts, and suggest that dysfunction of a member of the EphA-receptor tyrosine kinase sub-family triggers loss of lens transparency.

Appendix 1. Association results for SNPs in the EPHA2 region with age-related cataracts.


We thank family and case-control members for participating in this study, Dr. Olivera Boskovska for help with ascertaining family Mu, Dr. Donna Mackay for preliminary linkage analysis, Raffaella Aldigeri and Francesca Grassi for DNA preparation from the Italian case-control cohort, and the Microarray Core Facility at Washington University Genome Center, St. Louis, MO for SNP genotyping. This work was supported by NIH/NEI grants EY012284 (to A.S.) and EY02687, and FIL 2002–2003 grants (to G.M.).


  1. World Health Organization - Vision 2020; The Right to Sight, Global initiative for the elimination of avoidable blindness - Action plan 2006–2011 (
  2. SanGiovanni JP, Chew EY, Reed GF, Remaley NA, Bateman JB, Sugimoto TA, Klebanoff MA. Infantile cataract in the collaborative perinatal project: prevalence and risk factors. Arch Ophthalmol. 2002; 120:1559-65. [PMID: 12427072]
  3. Zetterstrom C, Lundvall A, Kugelberg M. Cataracts in children. J Cataract Refract Surg. 2005; 31:824-40. [PMID: 15899463]
  4. Shiels A, Hejtmancik JF. Genetic origins of cataract. Arch Ophthalmol. 2007; 125:165-73. [PMID: 17296892]
  5. Litt M, Kramer P, LaMorticella DM, Murphey W, Lovrien EW, Weleber RG. Autosomal dominant congenital cataract associated with a missense mutation in the human alpha crystallin gene CRYAA. Hum Mol Genet. 1998; 7:471-4. [PMID: 9467006]
  6. Berry V, Francis P, Reddy MA, Collyer D, Vithana E, MacKay I, Dawson G, Carey AH, Moore A, Bhattacharya SS, Quinlan RA. Alpha-B crystallin gene (CRYAB) mutation causes dominant congenital posterior polar cataract in humans. Am J Hum Genet. 2001; 69:1141-5. [PMID: 11577372]
  7. Mackay DS, Boskovska OB, Knopf HL, Lampi KJ, Shiels A. A nonsense mutation in CRYBB1 associated with autosomal dominant cataract linked to human chromosome 22q. Am J Hum Genet. 2002; 71:1216-21. [PMID: 12360425]
  8. Litt M, Carrero-Valenzuela R, LaMorticella DM, Schiltz DW, Mitchell TN, Kramer P. Autosomal dominant cerulean cataract is associated with a chain termination mutation in the human beta-crystallin gene CRYBB2. Hum Mol Genet. 1997; 6:665-8. [PMID: 9158139]
  9. Riazuddin SA, Yasmeen A, Yao W, Sergeev YV, Zhang Q, Zulfigar F, Riaz A, Riazuddin S, Hejtmancik JF. Mutations in betaB3-crystallin associated with autosomal recessive cataract in two Pakistani families. Invest Ophthalmol Vis Sci. 2005; 46:2100-6. [PMID: 15914629]
  10. Kannabiran C, Rogan PK, Olmos L, Basti S, Rao GN, Kaiser-Kupfer M, Hejtmancik JF. Autosomal dominant zonular cataract with sutural opacities is associated with a splice mutation in the betaA3/A1-crystallin gene. Mol Vis. 1998; 4:21 [PMID: 9788845]
  11. Billingsley G, Santhiya ST, Paterson AD, Ogata K, Wodak S, Hosseni SM, Manisastry SM, Vijajalakshmi P, Gopinah PM, Graw J, Heon E. CRYBA4, a novel human cataract gene, is also involved in microphthalmia. Am J Hum Genet. 2006; 79:702-9. [PMID: 16960806]
  12. Heon E, Priston M, Schorderet DF, Billingsley GD, Girard PO, Lubsen N, Munier FL. The gamma-crystallins and human cataracts: a puzzle made clearer. Am J Hum Genet. 1999; 65:1261-7. [PMID: 10521291]
  13. Sun H, Ma Z, Li Y, Liu B, Li Z, Ding X, Gao Y, Ma W, Tang X, Li X, Shen Y. Gamma-S crystallin gene (CRYGS) mutation causes dominant progressive cortical cataract in humans. J Med Genet. 2005; 42:706-10. [PMID: 16141006]
  14. Shiels A, Mackay D, Ionides A, Berry V, Moore A, Bhattacharya S. A missense mutation in the human connexin50 gene (GJA8) underlies autosomal dominant “zonular pulverulent” cataract, on chromosome 1q. Am J Hum Genet. 1998; 62:526-32. [PMID: 9497259]
  15. Mackay D, Ionides A, Kibar Z, Rouleau G, Berry V, Moore A, Shiels A, Bhattacharya S. Connexin46 mutations in autosomal dominant congenital cataract. Am J Hum Genet. 1999; 64:1357-64. [PMID: 10205266]
  16. Bu L, Jin Y, Shi Y, Chu R, Ban A, Eiberg H, Andres L, Jiang H, Zheng G, Qian M, Cui B, Xia Y, Liu J, Hu L, Zhao G, Hayden MR, Kong X. Mutant DNA-binding domain of HSF4 is associated with autosomal dominant lamellar and Marner cataract. Nat Genet. 2002; 31:276-8. [PMID: 12089525]
  17. Jamieson RV, Perveen R, Kerr B, Carette M, Yardley J, Heon E, Wirth MG, van Heyningen V, Donnai D, Munier F, Black GC. Domain disruption and mutation of the bZIP transcription factor, MAF, associated with cataract, ocular anterior segment dysgenesis and coloboma. Hum Mol Genet. 2002; 11:33-42. [PMID: 11772997]
  18. Semina EV, Ferrell RE, Mintz-Hittner HA, Bitoun P, Alward WL, Reiter RS, Funkhauser C, Daack-Hirsch S, Murray JC. A novel homeobox gene PITX3 is mutated in families with autosomal-dominant cataracts and ASMD. Nat Genet. 1998; 19:167-70. [PMID: 9620774]
  19. Berry V, Francis P, Kaushal S, Moore A, Bhattacharya S. Missense mutations in MIP underlie autosomal dominant 'polymorphic' and lamellar cataracts linked to 12q. Nat Genet. 2000; 25:15-7. [PMID: 10802646]
  20. Pras E, Levy-Nissenbaum E, Bakhan T, Lahat H, Assia E, Geffin-Carmi N, Frydman M, Goldman B, Pras E. A missense mutation in the LIM2 gene is associated with autosomal recessive presenile cataract in an inbred Iraqi Jewish family. Am J Hum Genet. 2002; 70:1363-7. [PMID: 11917274]
  21. Jamieson RV, Farrar N, Stewart K, Perveen R, Mihelec M, Carette M, Grigg JR, McAvoy JW, Lovicu FJ, Tam PP, Scambler P, Lloyd IC, Donnai D, Black GC. Characterization of a familial t(16;22) balanced translocation associated with congenital cataract leads to identification of a novel gene, TMEM114, expressed in the lens and disrupted by the translocation. Hum Mutat. 2007; 28:968-77. [PMID: 17492639]
  22. Conley YP, Erturk D, Keverline A, Mah TS, Keravala A, Barnes LR, Bruchis A, Hess JF, FitzGerald PG, Weeks DE, Ferrell RE, Gorin MB. A juvenile-onset, progressive cataract locus on chromosome 3q21-q22 is associated with a missense mutation in the beaded filament structural protein-2. Am J Hum Genet. 2000; 66:1426-31. [PMID: 10729115]
  23. Ramachandran RD, Perumalsamy V, Hejtmancik JF. Autosomal recessive juvenile onset cataract associated with mutation in BFSP1. Hum Genet. 2007; 121:475-82. [PMID: 17225135]
  24. Shiels A, Bennett TM, Knopf HL, Yamada K, Yoshiura K, Niikawa N, Shim S, Hanson PI. CHMP4B, a novel gene for autosomal dominant cataracts linked to chromosome 20q. Am J Hum Genet. 2007; 81:596-606. [PMID: 17701905]
  25. Kloeckener-Gruissem B, Vandekerckhove K, Nurnberg G, Neidhardt J, Zeitz C, Nurnberg P, Schipper I, Berger W. Mutation of solute carrier SLC16A12 associates with a syndrome combining juvenile cataract with microcornea and renal glucosuria. Am J Hum Genet. 2008; 82:772-9. [PMID: 18304496]
  26. Heiba IM, Elston RC, Klein BE, Klein R. Genetic etiology of nuclear cataract: evidence for a major gene. Am J Med Genet. 1993; 47:1208-14. [PMID: 8291558]
  27. Hammond CJ, Snieder H, Spector TD, Gilbert CE. Genetic and environmental factors in age-related nuclear cataracts in monozygotic and dizygotic twins. N Engl J Med. 2000; 342:1786-90. [PMID: 10853001]
  28. Congdon N, Broman KW, Lai H, Munoz B, Bowie H, Gilbert D, Wojciechowski R, Alston C, West SK. Nuclear cataract shows significant familial aggregation in an older population after adjustment for possible shared environmental factors. Invest Ophthalmol Vis Sci. 2004; 45:2182-6. [PMID: 15223793]
  29. Heiba IM, Elston RC, Klein BE, Klein R. Evidence for a major gene for cortical cataract. Invest Ophthalmol Vis Sci. 1995; 36:227-35. [PMID: 7822150]
  30. Hammond CJ, Duncan DD, Snieder H, de Lange M, West SK, Spector TD, Gilbert CE. The heritability of age-related cortical cataract: the twin eye study. Invest Ophthalmol Vis Sci. 2001; 42:601-5. [PMID: 11222516]
  31. Congdon N, Broman KW, Lai H, Munoz B, Bowie H, Gilbert D, Wojciechowski R, West SK. Cortical, but not posterior subcapsular, cataract shows significant familial aggregation in an older population after adjustment for possible shared environmental factors. Ophthalmology. 2005; 112:73-7. [PMID: 15629823]
  32. Hejtmancik JF, Kantorow M. Molecular genetics of age-related cataract. Exp Eye Res. 2004; 79:3-9. [PMID: 15183095]
  33. Okano Y, Asada M, Fujimoto A, Ohtake A, Murayama K, Hsiao KJ, Choeh K, Yang Y, Cao Q, Reichardt JK, Niihira S, Imamura T, Yamano T. A genetic factor for age-related cataract: identification and characterization of a novel galactokinase variant, “Osaka,” in Asians. Am J Hum Genet. 2001; 68:1036-42. [PMID: 11231902]
  34. Maraini G, Hejtmancik JF, Shiels A, Mackay DS, Aldigeri R, Jiao XD, Williams SL, Sperduto RD, Reed G. Galactokinase gene mutations and age-related cataract. Lack of association in an Italian population. Mol Vis. 2003; 9:397-400. [PMID: 12942049]
  35. Clinical Trial of Nutritional Supplements and Age-Related Cataract Study Group. A randomized, double-masked, placebo-controlled clinical trial of multivitamin supplementation for age-related lens opacities. Clinical trial of nutritional supplements and age-related cataract report no. 3. Ophthalmology. 2008; 115:599-607. [PMID: 18387406]
  36. Age Related Eye Disease Study Group. The age-related eye disease study (AREDS) system for classifying cataracts from photographs: AREDS report no. 4. Am J Ophthalmol. 2001; 131:167-75. [PMID: 11228291]
  37. Hoffmann K, Lindner TH. easyLINKAGE Plus – Automated linkage analyses using large scale SNP data. Bioinformatics. 2005; 21:3565-7. [PMID: 16014370]
  38. Mackay DS, Andley UP, Shiels A. Cell death triggered by a novel mutation in the alphaA-crystallin gene underlies autosomal dominant cataract linked to chromosome 21q. Eur J Hum Genet. 2003; 11:784-93. [PMID: 14512969]
  39. Lathrop GM, Lalouel JM, Julier C, Ott J. Strategies for multilocus linkage analysis in humans. Proc Natl Acad Sci USA. 1984; 81:3443-6. [PMID: 6587361]
  40. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005; 21:263-5. [PMID: 15297300]
  41. Wistow G, Peterson K, Gao J, Buchoff P, Jaworski C, Bowes-Rickman C, Ebright JN, Hauser MA, Hoover D. NEIBank: genomics and bioinformatics resources for vision research. Mol Vis. 2008; 14:1327-37. [PMID: 18648525]
  42. Himanen JP, Nikolov DB. Eph signaling: a structural view. Trends Neurosci. 2003; 26:46-51. [PMID: 12495863]
  43. Stapleton D, Balan I, Pawson T, Sicheri F. The crystal structure of an Eph receptor SAM domain reveals a mechanism for modular dimerization. Nat Struct Biol. 1999; 6:44-9. [PMID: 9886291]
  44. Iyengar SK, Klein BE, Klein R, Jun G, Schick JH, Millard C, Liptak R, Russo K, Lee KE, Elston RC. Identification of a major locus for age-related cortical cataract on chromosome 6p12-q12 in the Beaver Dam Eye Study. Proc Natl Acad Sci USA. 2004; 101:14485-90. [PMID: 15452352]
  45. Eiberg H, Lund AM, Warburg M, Rosenberg T. Assignment of congenital cataract Volkmann type (CCV) to chromosome 1p36. Hum Genet. 1995; 96:33-8. [PMID: 7607651]
  46. Ionides AC, Berry V, Mackay DS, Moore AT, Bhattacharya SS, Shiels A. A locus for autosomal dominant posterior polar cataract on chromosome 1p. Hum Mol Genet. 1997; 6:47-51. [PMID: 9002669]
  47. McKay JD, Patterson B, Craig JE,, Russell-Eggitt IM, Wirth MG, Burdon KP, Hewitt AW, Cohn AC, Kerdraon Y, Mackey DA. The telomere of human chromosome 1p contains at least two independent autosomal dominant congenital cataract genes. Br J Ophthalmol. 2005; 89:831-4. [PMID: 15965161]
  48. Brittis PA, Lu Q, Flanagan JG. Axonal protein synthesis provides a mechanism for localized regulation at an intermediate target. Cell. 2002; 110:223-35. [PMID: 12150930]
  49. Winter J, Roepcke S, Krause S, Muller EC, Otto A, Vingron M, Schweiger S. Comparative 3′UTR analysis allows identification of regulatory clusters that drive Eph/ephrin expression in cancer cell lines. PLoS One. 2008; 3:e2780 [PMID: 18648668]
  50. Pasquale EB. Eph receptor signaling casts a wide net on cell behaviour. Nat Rev Mol Cell Biol. 2005; 6:462-7. [PMID: 15928710]
  51. Pasquale EB. Eph-ephrin bidirectional signaling in physiology and disease. Cell. 2008; 133:38-52. [PMID: 18394988]
  52. Cooper MA, Son AI, Komlos D, Sun Y, Kleiman NJ, Zhou R. Loss of ephrin-A5 function disrupts lens fiber cell packing and leads to cataract. Proc Natl Acad Sci USA. 2008; 105:16620-5. [PMID: 18948590]